Psychotropic drug treatment of mixed anxiety and depression in nonpsychiatric office patients: Expected and unexpected findings - comparing doxepin, chlordiazepoxide and placebo

B. J. Goldstein, B. Brauzer, R. M. Steinbook, A. F. Jacobson

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The present study was designed to compare the efficacy of doxepin (a tricyclic antidepressant with antianxiety properties), chlordiazepoxide (a benzodiazepine antianxiety compound), and placebo in nonpsychiatric, moderately anxious depressed patients commonly seen by a family practitioner. Patients treated with doxepin improved significantly by a reduction in the severity of symptoms of anxiety and depression. Daytime drowsiness, a major complaint of middle class patients, was alleviated by prescribing the major portion of the daily dosage at bedtime, an important implication in the prescribing of psychotropic drugs. The inability to demonstrate significant improvement in patients treated with chlordiazepoxide as compared to placebo was unexpected, and alerts us to recognize nondrug factors and their influence on treatment outcome as well as the possible effects of previous medication on drug tolerance.

Original languageEnglish
Pages (from-to)892-897
Number of pages6
JournalSouthern Medical Journal
Volume66
Issue number8
StatePublished - Dec 1 1973
Externally publishedYes

Fingerprint

Doxepin
Chlordiazepoxide
Psychotropic Drugs
Anxiety
Placebos
Depression
Drug Tolerance
Tricyclic Antidepressive Agents
Sleep Stages
Therapeutics
Benzodiazepines

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Psychotropic drug treatment of mixed anxiety and depression in nonpsychiatric office patients : Expected and unexpected findings - comparing doxepin, chlordiazepoxide and placebo. / Goldstein, B. J.; Brauzer, B.; Steinbook, R. M.; Jacobson, A. F.

In: Southern Medical Journal, Vol. 66, No. 8, 01.12.1973, p. 892-897.

Research output: Contribution to journalArticle

@article{2cdb5491d33b47a489289f9484674d72,
title = "Psychotropic drug treatment of mixed anxiety and depression in nonpsychiatric office patients: Expected and unexpected findings - comparing doxepin, chlordiazepoxide and placebo",
abstract = "The present study was designed to compare the efficacy of doxepin (a tricyclic antidepressant with antianxiety properties), chlordiazepoxide (a benzodiazepine antianxiety compound), and placebo in nonpsychiatric, moderately anxious depressed patients commonly seen by a family practitioner. Patients treated with doxepin improved significantly by a reduction in the severity of symptoms of anxiety and depression. Daytime drowsiness, a major complaint of middle class patients, was alleviated by prescribing the major portion of the daily dosage at bedtime, an important implication in the prescribing of psychotropic drugs. The inability to demonstrate significant improvement in patients treated with chlordiazepoxide as compared to placebo was unexpected, and alerts us to recognize nondrug factors and their influence on treatment outcome as well as the possible effects of previous medication on drug tolerance.",
author = "Goldstein, {B. J.} and B. Brauzer and Steinbook, {R. M.} and Jacobson, {A. F.}",
year = "1973",
month = "12",
day = "1",
language = "English",
volume = "66",
pages = "892--897",
journal = "Southern Medical Journal",
issn = "0038-4348",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Psychotropic drug treatment of mixed anxiety and depression in nonpsychiatric office patients

T2 - Expected and unexpected findings - comparing doxepin, chlordiazepoxide and placebo

AU - Goldstein, B. J.

AU - Brauzer, B.

AU - Steinbook, R. M.

AU - Jacobson, A. F.

PY - 1973/12/1

Y1 - 1973/12/1

N2 - The present study was designed to compare the efficacy of doxepin (a tricyclic antidepressant with antianxiety properties), chlordiazepoxide (a benzodiazepine antianxiety compound), and placebo in nonpsychiatric, moderately anxious depressed patients commonly seen by a family practitioner. Patients treated with doxepin improved significantly by a reduction in the severity of symptoms of anxiety and depression. Daytime drowsiness, a major complaint of middle class patients, was alleviated by prescribing the major portion of the daily dosage at bedtime, an important implication in the prescribing of psychotropic drugs. The inability to demonstrate significant improvement in patients treated with chlordiazepoxide as compared to placebo was unexpected, and alerts us to recognize nondrug factors and their influence on treatment outcome as well as the possible effects of previous medication on drug tolerance.

AB - The present study was designed to compare the efficacy of doxepin (a tricyclic antidepressant with antianxiety properties), chlordiazepoxide (a benzodiazepine antianxiety compound), and placebo in nonpsychiatric, moderately anxious depressed patients commonly seen by a family practitioner. Patients treated with doxepin improved significantly by a reduction in the severity of symptoms of anxiety and depression. Daytime drowsiness, a major complaint of middle class patients, was alleviated by prescribing the major portion of the daily dosage at bedtime, an important implication in the prescribing of psychotropic drugs. The inability to demonstrate significant improvement in patients treated with chlordiazepoxide as compared to placebo was unexpected, and alerts us to recognize nondrug factors and their influence on treatment outcome as well as the possible effects of previous medication on drug tolerance.

UR - http://www.scopus.com/inward/record.url?scp=0015789803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015789803&partnerID=8YFLogxK

M3 - Article

C2 - 4578609

AN - SCOPUS:0015789803

VL - 66

SP - 892

EP - 897

JO - Southern Medical Journal

JF - Southern Medical Journal

SN - 0038-4348

IS - 8

ER -